Oclusión y/o trombosis venosa de la retina del ojo. Mujer transexual (página 2)

37. Lip GY, Beevers M, Churchill D, Beevers DG. Hormone replacement therapy and blood pressure in hypertensive women. J Hum Hypertens 1994;8:491–4. 

38. Lobo RA, Speroff L. International consensus conference on postmenopausal hormone therapy and the cardiovascular system. Fertil Steril 1994;61:592–5. 

39. Lobo RA. The role of progestins in hormone replacement therapy. Am J Obstet Gynecol 1992;166:1997–2003. 

40. M. Cahill,M. Karabatzaki,R. Meleady,H. Refsum,P. Ueland,D. Shields Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease Br J Ophthalmol., 84 (2000), pp. 154-157

41. M.D. Tsaloumas,J. Kirwan,H. Vinall,M. O"Leary,P. Prior,E.E. Kritzinger Nine year follow up study of morbidity and mortality in retinal vein occlusion Eye., 14 (2000), pp. 821-827

42. Magargal LE, Brown GC, Augsburger JJ, Donoso LA. Efficacy of photocoagulation in preventing neovascular glaucoma following ischemic central retinal vein obstruction. Ophthalmology 1982;89:780-4.

43. Magargal LE, Brown GC, Augsburger JJ, Donoso LA. La eficacia de la fotocoagulación en la prevención del glaucoma neovascular siguiente obstrucción de la vena central de la retina ischeic Ophthalmology 1982; 89:. 780-4.

44. Magargal LE, Donoso LA, Sanborn GE. Isquemia retiniana y el riesgo de neovascularización tras obstrucción de la vena central de la retina Ophthalmology 1982; 89:. 1241-5.

45. McGrath MA, Wechsler M, Hunyor AB, Penny R. Factores sistemicos que contribuyen a la oclusión venosa retiniana Arch Intern Med 1978; 138:. 216-20.

46. Meade TW, Berra A. Hormone replacement therapy and cardiovascular disease. Br Med Bull 1992;48:276–308

47. Meade TW, Stanwell-Smith R. Hormone replacement therapy for menopausal women: a review of its effects on homeostatic function, lipids, and blood pressure. Adv Drug Reac Rev 1984;4:187–210.

48. Minturn J, Brown GC. Progression of nonischemic central retinal vein obstruction to the isqchemic variante. Ophthalmology. 1986;93:1158–62.

49. N. Ehlers Thrombophilia: a feature of importance in retinal vein thrombosis? Acta Ophthalmol Scand, 77 (1999), pp. 619-621

50. Paton A, Rubinstein K, Smith VH. La insuficiencia arterial en la oclusión venosa retiniana Trans Ophthalmol Soc UK 1964; 84:. 559-86.

51. Prentice RL. On the ability of blood pressure effects to explain the relation between oral contraceptives and cardiovascular disease. Am J Epidemiol 1988;127:213–9. 

52. Priluck IA, Robertson DM, Hollenhorst RW. A largo plazo de seguimiento de la oclusión de la vena central de la retina en adultos jóvenes Am J Ophthalmol 1980; 90:. 190-202. |

53. Priluck IA. Inminente obstrucción de la vena central de la retina asociada con un aumento de la agregabilidad plaquetaria Ann Ophthalmol 1979; 11:. 79-84

54. Priluck lA, Robertson DM, Hollenhorst RW. Long-term follow-up of occlusion of the central retinal vein in young adults. Am J Ophthalmol 1980;90:190-202.

55. R.D. Sperduto,R. Hiller,E. Chew,D. Seigel,N. Blair,T.C. Burton Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the eye disease case-control study Ophthalmology., 105 (1998), pp. 765-771

56. Rabinowicz IM, Litman S, Michaelson IC. Branch venous thrombosis: a pathological report. Trans Ophthalmol Soc UK 1968;88:191–210.

57. Rakobowchuk M, McGowan CL, de Groot PC, Hartman J W, Phillips SM, MacDonald MJ. Endothelial function of young healthy males following whole body resistance training. J Appl Physiol. 2005;98:2185-90.

58. Rinder MR, Spina RJ, Ehsani AA. Enhanced endothelium-dependent vasodilation in older endurance-trained men. J Appl Physiol. 2000;88:761-6.

59. Rywik TM, Blackman MR, Yataco AR, Vaitkevicius PV, Zink RC, Cottrell EH, et al. Enhanced endothelial vasoreactivity in endurance-trained older men. J Appl Physiol. 1999;87(6):2136-42.

60. S.S. Hayreh Prevalent misconceptions about acute retinal vascular occlusive disorders Prog Retin Eye Res., 24 (2005), pp. 493-519

61. S.S. Hayreh,M.S. Hayreh Hemi-central retinal vein occlusion. Pathogenesis, clinical features, and natural history Arch Ophthalmol., 98 (1980), pp. 1600-1609

62. Schjerve IE, Tyldum GA, Tjønna AE, Stølen T, Loennechen JP, Hansen HE, et al. Both aerobic endurance and strength training programmes improve cardiovascular health in obese adults. Clin Sci (Lond). 2008;115(9):28393.

63. Sciacqua A, Candigliota M, Ceravolo R, Scozzafava A, Sinopoli F, Corsonello A, et al. Weight loss in combination with physical activity improves endothelial dysfunction in human obesity. Diabetes Care. 2003;26(6):1673-8.

64. Scott,B.A. Blodi,M.S. Ip,P.C. Vanveldhuisen,N.L. Oden,C.K. Chan,Score Study Investigator Group Score Study report 2: Interobserver agreement between investigador and Redding center classification of retinal vein occlusion type Opthalmology., 116 (2009), pp. 756-761

65. Sorsby A. The incidence and causes of blindness in England and Wales. London: HMSO, 1978:1963–8.

66. Sowais GE, Thompson HS, Hayreh SS. Relative afferent pupillary defect in central retinal vein occlusion. Ophthalmolog. 1986;93:301-3.

67. Sowais GE, Thompson SA, Hayreh SS. Defecto pupilar aferente relativo en la oclusión de la vena central de la retina Ophthalmology 1986; 93:. 301-3.

68. T.H. Williamson,A. Rumley,G.D. Lowe Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study Br J Ophthalmol., 80 (1996), pp. 203-208

69. Thorogood M, Villard-Macintosh L. Combined oral contraceptives: risks and benefits. Br Med Bull 1993;49:124–39.

70. Tjønna AE, Lee SJ, Rognmo Ø, Stølen TO, Bye A, Haram PM, et al. Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study. Circulation. 2008;118(4):346-54.

71. Vessey MP, Lawless M, Yeates D. Oral contraceptives and stroke: findings in a large prospective study. BMJ 1984;289:530–1. 

72. Vessey MP. Female hormones and vascular disease: an epidemiological overview. Br J Farn Plann 1980;6:1–12.

73. W.R. Green,C.C. Chan,G.M. Hutchins,M. Terry Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases Trans Am Ophthalmol Soc., 79 (1981), pp. 371-422

74. Walsh JH, Yong G, Cheetham C, Watts GF, O"Driscoll GJ, et al. Effects of exercise training on conduit and resistance vessel function in treated and untreated hypercholesterolaemic subjects. Eur Heart J. 2003;24(18):1681-9.

75. Walters RF, SpaJton DJ. Central retinal vein occlusion in people aged 40 years or less: a review of 17 patients. Br J Ophthalmol 1990;74:30-5..

76. Wang J, Widlansky ME. Lifestyle choices and endothelial function: risk and relevance. Curr Vasc Pharmacol. 2009;7(2):209-24.

77. Watts K, Beye P, Siafarikas A, Davis EA, Jones TW, O"Driscoll G, et al. Exercise training normalizes vascular dysfunction and improves central adiposity in obese adolescents. J Am Coll Cardiol. 2004;43(10):1823-7.

78. Woo KS, Chook P, Yu CW, Sung RY, Qiao M, Leung SS, et al. Effects of diet and exercise on obesity-related vascular dysfunction in children. Circulation. 2004;109(16):1981-6.

79. Wycherley TP, Brinkworth GD, Noakes M, Buckley JD, Clifton PM. Effect of caloric restriction with and without exercise training on oxidative stress and endothelial function in obese subjects with type 2 diabetes. Diabetes Obes Metab. 2008;10(11):1062-73.

80. Wynn V, Adams PW, Godsland I, et al. Comparison of effects of different combined oral-contraceptives on carbohydrate and lipid metabolism. Lancet 1979;1:1049–54. | PubMed |

81. Zegarra H, Gutman FA, Conforto J. The natural course of central retinal vein occlusion. Ophthalmology 1979;86: 1931-9.